You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

SPECTAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Spectamine, and what generic alternatives are available?

Spectamine is a drug marketed by IMP and is included in one NDA.

The generic ingredient in SPECTAMINE is iofetamine hydrochloride i-123. Additional details are available on the iofetamine hydrochloride i-123 profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SPECTAMINE?
  • What are the global sales for SPECTAMINE?
  • What is Average Wholesale Price for SPECTAMINE?
Summary for SPECTAMINE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 42
Patent Applications: 17
DailyMed Link:SPECTAMINE at DailyMed
Drug patent expirations by year for SPECTAMINE

US Patents and Regulatory Information for SPECTAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Imp SPECTAMINE iofetamine hydrochloride i-123 INJECTABLE;INJECTION 019432-001 Dec 24, 1987 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SPECTAMINE

See the table below for patents covering SPECTAMINE around the world.

Country Patent Number Title Estimated Expiration
Singapore 23186 ⤷  Subscribe
Japan S5932457 ⤷  Subscribe
Japan S5573640 RADIATIVE IODINATED AMINE ⤷  Subscribe
European Patent Office 0011858 RADIOIODINE CONTAINING AMINES, THEIR PREPARATION AND THEIR USE AS BRAIN IMAGING AGENTS ⤷  Subscribe
Germany 2965469 ⤷  Subscribe
Hong Kong 65586 RADIOIODINE CONTAINING AMINES,THEIR PREPARATION AND THEIR USE AS BRAIN IMAGING AGENTS ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.